Antibody seen in neonatal lupus with congenital heart block:
**Core Concept**
Neonatal lupus is a rare condition where a fetus is affected by the mother's autoimmune disease, lupus. Congenital heart block is a complication of this condition, where the electrical conduction system of the heart is disrupted. The underlying mechanism involves the transfer of autoantibodies from the mother to the fetus.
**Why the Correct Answer is Right**
The correct antibody associated with neonatal lupus and congenital heart block is anti-Ro (SS-A) antibody. This autoantibody can cross the placenta from the mother to the fetus and bind to the cardiac conduction system, leading to the disruption of the heart's electrical activity. The binding of anti-Ro antibody to the cardiac conduction system can cause fibrosis and scarring, resulting in congenital heart block.
**Why Each Wrong Option is Incorrect**
**Option A:** Anti-La (SS-B) antibody is also associated with lupus, but it is not the primary antibody responsible for congenital heart block.
**Option B:** Rheumatoid factor is an antibody that is often present in patients with rheumatoid arthritis, but it is not directly associated with neonatal lupus or congenital heart block.
**Option C:** Anti-SS-A antibody is a synonym for anti-Ro antibody, and while both terms are correct, anti-Ro is the more commonly used term in this context.
**Clinical Pearl / High-Yield Fact**
Neonatal lupus with congenital heart block is a rare but serious complication of maternal lupus. The presence of anti-Ro antibody in the mother is a significant risk factor for this condition, and fetal monitoring is essential to prevent long-term cardiac damage.
**Correct Answer:** C. Anti-Ro (SS-A) antibody.